Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | STAT3 | P40763 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | PKM | P14618 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.34 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1532439 | 1.00 | CYP2A6 (0.44) | CYP2A6CHRNA7ACHETDP1STAT3 | |
| SCHEMBL4831627 | 1.00 | CYP2A6 (0.44) | CYP2A6CHRNA7ACHETDP1STAT3 | |
| Isobutane SCHEMBL19460561 | 0.98 | CYP2A6 (0.42) | CYP2A6CHRNA7ACHETDP1STAT3 | |
| SCHEMBL21628043 | 0.89 | TYR (0.46) | TYR | |
| SCHEMBL2768678 | 0.88 | CHRNA7 (0.38) | CYP2A6CHRNA7ACHETDP1STAT3 | |
| SCHEMBL28164329 | 0.88 | L3MBTL1 (0.42) | CYP2A6ACHETDP1STAT3ALOX5 | |
| SCHEMBL9717427 | 0.84 | ALDH1A1 (0.38) | CYP2A6ACHETDP1STAT3ALOX5 | |
| SCHEMBL29595346 | 0.82 | TYR (0.41) | TYRGRIA4 | |
| SCHEMBL454717 | 0.82 | TYR (0.58) | TYRGAAALDH1A1HTTLMNA | |
| SCHEMBL874206 | 0.82 | TYR (0.58) | TYRGAAALDH1A1HTTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3398585-B1 | EXTERNAL DERMAL COMPOSITION FOR ANTI-AGEING AND METHOD FOR PRODUCING THE SAME | HAYASHIBARA CO (JP) | 2020-02-26 | — | — | EP | disclosed |
| US-10309212-B2 | Energetic cocrystals for treatment of a subterranean formation | HALLIBURTON ENERGY SERVICES, INC. (US) | 2019-06-04 | — | — | US | disclosed |
| US-10253244-B2 | Scale-inhibiting cocrystals for treatment of a subterranean formation | HALLIBURTON ENERGY SERVICES, INC. (US) | 2019-04-09 | — | — | US | disclosed |
| US-20190008747-A1 | EXTERNAL DERMAL COMPOSITION FOR ANTI-AGEING AND METHOD FOR PRODUCING THE SAME | Hayashibara Co., Ltd. (JP) | 2019-01-10 | — | — | US | disclosed |
| EP-3398585-A1 | EXTERNAL DERMAL COMPOSITION FOR ANTI-AGEING AND METHOD FOR PRODUCING THE SAME | Hayashibara Co., Ltd. (JP) | 2018-11-07 | — | — | EP | disclosed |
| US-10111822-B2 | External dermal composition for anti-ageing and method for producing the same | Hayashibara Co., Ltd. (JP) | 2018-10-30 | — | — | US | disclosed |
| EP-2939657-B1 | SKIN-EXTERIOR ANTI-AGEING COMPOSITION AND PRODUCTION METHOD THEREFOR | HAYASHIBARA CO (JP) | 2018-08-08 | — | — | EP | disclosed |
| US-10015984-B2 | Disintegrable capsule, manufacturing method for same, and smoking device containing said disintegrable capsule | SUNSHO PHARMACEUTICAL CO., LTD. (JP) | 2018-07-10 | — | — | US | disclosed |
| US-10006151-B2 | Polyurethane fiber | TORAY OPELONTEX CO., LTD. (JP) | 2018-06-26 | — | — | US | disclosed |
| US-9975831-B2 | Method for producing ether compound | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2018-05-22 | — | — | US | disclosed |
| US-20090087401-A1 | DEODORANT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20080085251-A1 | even at a neutral to weakly acidic pH; a lactone or lactam having a mercapto group; with thioglycolic acid, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine; | RESONAC CORPORATION (JP) | 2008-04-10 | — | — | US | disclosed |
| EP-1827370-A1 | HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR | Showa Denko K.K. (JP) | 2007-09-05 | — | — | EP | disclosed |
| US-20060165622-A1 | Deodorant composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-07-27 | — | — | US | disclosed |
| WO-2006068276-A1 | HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR | SHOWA DENKO K.K. (JP) | 2006-06-29 | — | — | WO | disclosed |
| EP-1561476-A1 | DEODORANT COMPOSITION | Takasago International Corporation (JP) | 2005-08-10 | — | — | EP | disclosed |
| EP-0345966-B1 | Compositions containing chlorine dioxide and their preparation | JOHNSON & SON INC S C (US) | 1994-12-14 | — | — | EP | disclosed |
| EP-0345966-A2 | Compositions containing chlorine dioxide and their preparation | S.C. JOHNSON & SON, INC. (US) | 1989-12-13 | — | — | EP | disclosed |
| US-4861514-A | Compositions containing chlorine dioxide and their preparation | THE DRACKETT COMPANY (US) | 1989-08-29 | — | — | US | disclosed |
| EP-0174821-A2 | Methods of treating vegetable foods for animals and fragrance compositions for use therein | A.B.M. CHEMICALS LIMITED (GB) | 1986-03-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080085251-A1 | even at a neutral to weakly acidic pH; a lactone or lactam having a mercapto group; with thioglycolic acid, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine; | TST, CYSLTR1, CYSLTR2 | CYP2A6 19/4885CHRNA7 1806/4885ACHE 1176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.